23.8 C
Byron Shire
October 19, 2021

Nurofen feels pain from false pill claims

Latest News

Entertainment in the Byron Shire for the week beginning 19 October, 2021

Check out what's on at the cinema this week in Ballina and Byron

Other News

Cultural heritage report goes public

A redacted copy of the 2013 Ainsworth Cultural Heritage Impact Assessment document has been made publicly available on the Rous County Council website, clarifying the extensive Widjabul-Wiabul connections with the land which would have been inundated by the Dunoon Dam.

Iona Herbs

Pam Morrow from Iona Herbs is a one-woman-show. She has spent her whole life growing herbs and produce on...

Hundreds queue to have COVID test and two new cases in the NNSWLHD

Northern NSW Local Health District (NNSWLHD) is urging people to continue coming forward for testing and vaccination after two further COVID-19 cases were reported in the 24 hours to 8pm last night, October 14. 


The other day I met a Mullumbimby doctor. As I used to live in Mullum and Mullum was in...

One new COVID case in Lismore and Local Health District venues of concerns

Northern NSW Local Health District says there has been one new case of COVID-19 reported for the are to 8pm 17 October.

Byron cycling

Somewhere there is a book of rules for cycling in Byron, but I haven’t had any luck getting hold...

Nurofen for period pain: the Federal Court has ruled against a range of identical but specially targeted, higher priced Nurofen products, saying they are ripping off customers.
Nurofen for period pain: the Federal Court has ruled against a range of identical but specially targeted, higher priced Nurofen products, saying they are ripping off customers.

The consumer watchdog has given Nurofen a major headache.

The painkiller-maker has been ordered to pull its targeted pain relief range off shop shelves and could be fined more than $1 million after the Federal Court ruled it misled consumers.

Reckitt Benckiser, the company behind Nurofen, has admitted to peddling identical products that were marketed to treat specific types of pain, and for almost double the price.

The competition watchdog launched court action against the UK-based pharmaceutical giant earlier this year, alleging Nurofen’s treatments for back pain, period pain, migraine pain and tension headaches all contained the same active ingredient, ibuprofen lysine 342mg.

Nurofen spokesperson Montse Pena said Nurofen did not set out to mislead consumers.

“Nurofen has co-operated with the ACCC in relation to these proceedings and will fully comply with the court order made today,” she said in a statement on Monday.

Australian Competition and Consumer Commission chairman Rod Sims said the price of Nurofen’s targeted pain relief range was significantly higher than similar painkillers.

“The Nurofen specific pain products were being sold at retail prices almost double that of Nurofen’s standard ibuprofen products and the general pain relief products of its competitors,” he said.

The Federal Court has ordered Reckitt Benckiser to remove the products from stores within three months and amend packets so consumers know that other painkillers are just as suitable.

The multinational was also ordered to publish website and newspaper articles to clarify the status of the drugs, introduce a consumer protection compliance program and pay the ACCC’s legal costs.

A court hearing about a likely fine is yet to be scheduled, but there are penalties of up to $1.1 million per offence.

“I imagine there is more than one contravention … but the penalties clearly should be significant,” Mr Sims said.

Ms Pena said Nurofen’s targeted range was launched to help consumers work out their pain relief options, “particularly within the grocery environment where there is no healthcare professional to assist decision making”.

But Mr Sims said the company was taking advantage of people’s medical ignorance for profit.

“They were clearly, in our view, trying to mislead consumers to buy something they might not otherwise have bought, and pay more for it,” he said.

He said any representations which are difficult for a consumer to test will now face greater scrutiny from the ACCC.

“We’re definitely having a crackdown on (companies) misleading consumers about health claims,” Mr Sims said.

“There’ll be more cases in the new year.”

Australian Pain Management Association chief executive Elizabeth Carrigan welcomed the Federal Court’s decision, saying people living with pain are vulnerable to Reckitt Benckiser’s “exploitative” pricing regime.

“We hope that the penalty to be imposed by the court will be sufficiently sizeable to dissuade other companies from making unsubstantiated claims,” she said.

Support The Echo

Keeping the community together and the community voice loud and clear is what The Echo is about. More than ever we need your help to keep this voice alive and thriving in the community.

Like all businesses we are struggling to keep food on the table of all our local and hard working journalists, artists, sales, delivery and drudges who keep the news coming out to you both in the newspaper and online. If you can spare a few dollars a week – or maybe more – we would appreciate all the support you are able to give to keep the voice of independent, local journalism alive.


Please enter your comment!
Please enter your name here

Iona Herbs

Pam Morrow from Iona Herbs is a one-woman-show. She has spent her whole life growing herbs and produce on the Tyagarah property where she...

The Great Reopening

S Haslam What a time to go out in Byron – easy to park and, for the shy retiring types like myself, a less frantic...

Bring your people together!

It’s time to bring people together! Wherever you might like to party, Event Byron Bay has you covered. From dining table set-ups to the...

Cr Darlene Cook: ‘working to restore accountability and trust in our Council’

Current Lismore Councillor Darlene Cook has served one term on Lismore Council and at the December LAG election, she plans to run for Mayor.